comparemela.com

Latest Breaking News On - சுஷ்மா போப்பனா - Page 1 : comparemela.com

Sri Chaitanya on-boards Ujjwal Singh as its new CEO for its EdTech Initiative

Hyderabad (Telangana) [India], June 3 (ANI/PRNewswire): One of Asia's largest education group, Sri Chaitanya hires Ujjwal Singh as the CEO for its new EdTech Business. Ujjwal will be spearheading the overall management and drive the vision and growth of this new entity.

Study: Individuals recovering from COVID-19 helpful for Sustained cellular immune dysregulation

Study: Individuals recovering from COVID-19 helpful for Sustained cellular immune dysregulation ANI | Updated: Jan 03, 2021 22:10 IST Birmingham [UK], January 3 (ANI): A recent study has determined that Covid-19 patients might be helpful for clinicians to better understand how the unknown SARS-CoV-2 virus acts. According to a study published in the Journal of Clinical Investigation, many infected patients remain asymptomatic or have mild symptoms. Others, especially those with comorbidities, can develop severe clinical disease with atypical pneumonia and multiple system organ failures. Since the first cases were reported in December 2019, the SARS-CoV-2 virus that causes COVID-19 has surged into a pandemic, with cases and deaths still mounting. Ongoing observational clinical research has become a priority to better understand how this previously unknown virus acts, and findings from this research can better inform treatment and vaccine desig

Study finds sustained cellular immune dysregulation in patients recovering from COVID-19

Study finds sustained cellular immune dysregulation in patients recovering from COVID-19 ANI | Updated: Jan 02, 2021 23:14 IST Birmingham [UK], January 2 (ANI): Findings from recent researches on COVID-19 and observational clinical research of COVID-19 patients can help clinicians explore more about the virus to better inform treatment and vaccine design. The University of Alabama at Birmingham researchers, led by first-author Jacob Jake Files and co-senior authors Nathan Erdmann, M.D., PhD, and Paul Goepfert, M.D., have now reported their observational study, Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection, published in the Journal of Clinical Investigation. COVID-19, which has killed 1.7 million people worldwide, does not follow a uniform path. Many infected patients remain asymptomatic or have mild symptoms. Others, especially those with comorbidities, can develop severe clinical disease wit

Sustained cellular immune dysregulation in COVID patients

Sustained cellular immune dysregulation in COVID patients
birminghamstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from birminghamstar.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.